SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+16.34%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$664M
AUM Growth
+$664M
(+47%)
Cap. Flow
+$183M
Cap. Flow
% of AUM
27.61%
Top 10 Holdings %
Top 10 Hldgs %
99.99%
Holding
12
New
2
Increased
7
Reduced
–
Closed
1
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$47.1M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$29.8M |
| 3 |
MDCO
Medicines Co
MDCO
|
$23.9M |
| 4 |
Mersana Therapeutics
MRSN
|
$19.7M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$17.5M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$174K |
Sector Composition
| 1 | Healthcare | 84.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $127M | 19.13% | 868,000 +321,500 | +59% | +$47.1M |
|
2
Biogen
BIIB
$19.4B
| $124M | 18.67% | 524,658 +62,800 | +14% | +$14.8M |
|
|
3
Ironwood Pharmaceuticals
IRWD
$214M
| $102M | 15.36% | 7,542,200 +1,289,900 | +21% | +$17.5M |
|
|
MDCO
4
DELISTED
Medicines Co
MDCO
| $102M | 15.3% | 3,636,000 +855,000 | +31% | +$23.9M |
|
5
Innoviva
INVA
$1.29B
| $84.5M | 12.73% | 6,026,100 +975,000 | +19% | +$13.7M |
|
6
Puma Biotechnology
PBYI
$254M
| $55M | 8.27% | 1,417,000 +74,000 | +6% | +$2.87M |
|
|
ICPT
7
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $35.8M | 5.39% | 320,000 +266,000 | +493% | +$29.8M |
|
|
8
Mersana Therapeutics
MRSN
$36.5M
| $19.7M | 2.97% | +3,750,000 | New | +$19.7M |
|
9
Jazz Pharmaceuticals
JAZZ
$7.75B
| $14.3M | 2.15% | +100,000 | New | +$14.3M |
|
10
AbbVie
ABBV
$372B
| $80K | 0.01% | 1,000 | – | – |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $73K | 0.01% | 1,000 | – | – |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| – | – | -1,000 | Closed | -$174K |
|